Joint Filing Agreement
Exhibit 99.1
The undersigned hereby agree that the Statement on Schedule 13G dated April 9, 2018 with respect to the Ordinary Shares, par value of NIS 0.07, of Arcturus Therapeutics Ltd., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Dated: April 9, 2018
| XXXXX CAPITAL PARTNERS, L.P. | |||
| By: | Exodus Management Israel Ltd. | ||
| Its General Partner | |||
| By: | /s/ Xxxx Xxxxxx | ||
| Name: | Xxxx Xxxxxx | ||
| Title: | Authorized Signatory | ||
| EXODUS MANAGEMENT ISRAEL LTD. | |||
| By: | /s/ Xxxx Xxxxxx | ||
| Name: | Xxxx Xxxxxx | ||
| Title: | Authorized Signatory | ||
| /s/ Xxxx Xxxxxx | |
|
Xxxx Xxxxxx Individually, and as attorney-in-fact for Xxxxxx Xxxxx and Ester Deutsch |
